Home > Cashflow Statement > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
Cashflow Statement

LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

LINCOLN PHARMACEUTICALS Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax₹109 Cr₹122 Cr₹100 Cr₹96 Cr₹84 Cr
Adjustment ₹0.96 Cr₹-17 Cr₹-0.23 Cr₹1.48 Cr₹4.84 Cr
Changes In working Capital ₹9.17 Cr₹-16 Cr₹-31 Cr₹2.40 Cr₹0.20 Cr
Cash Flow after changes in Working Capital ₹119 Cr₹89 Cr₹69 Cr₹100 Cr₹89 Cr
Cash Flow from Operating Activities ₹93 Cr₹63 Cr₹39 Cr₹76 Cr₹69 Cr
Cash Flow from Investing Activities ₹-79 Cr₹-57 Cr₹-37 Cr₹-78 Cr₹-64 Cr
Cash Flow from Financing Activities ₹-6.40 Cr₹-5.18 Cr₹-4.50 Cr₹-2.56 Cr₹-5.75 Cr
Net Cash Inflow / Outflow ₹7.67 Cr₹0.70 Cr₹-1.88 Cr₹-4.50 Cr₹-0.70 Cr
Opening Cash & Cash Equivalents ₹5.75 Cr₹5.05 Cr₹6.93 Cr₹11 Cr₹12 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹13 Cr₹5.75 Cr₹5.05 Cr₹6.93 Cr₹11 Cr

Compare Cashflow Statement of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹1,221.7 Cr 2.4% -4.2% 8.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,603.0 Cr -5.6% -2.5% -1.7% Stock Analytics
DIVIS LABORATORIES ₹155,485.0 Cr -2.6% -8.7% 1.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,009.0 Cr -7.2% -8% 27.6% Stock Analytics
DR REDDYS LABORATORIES ₹101,628.0 Cr -6.5% -5.4% 3.9% Stock Analytics
CIPLA ₹96,400.8 Cr -4.1% -11.5% -19% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

2.4%

-4.2%

8.5%

SENSEX

-1%

-10.9%

-6%


You may also like the below Video Courses